| Bioactivity | DA-JC4 is a dual GLP-1/GIP receptor agonist and can be used for the research of neurological disease and insulin signaling pathways[1][2][3]. | ||||||
| Invitro | DA-JC4 (1~100 nM; hippocampal cells) inhibits rotenone-induced hippocampal neuron death and significantly suppresses Cyt C, Bax and Caspase activation[3]. | ||||||
| Name | DA-JC4 | ||||||
| CAS | 2315504-40-4 | ||||||
| Shortening | Y-{aminoisobutyric acid}-EGTFTSDYSIYLDKQAA-{aminoisobutyric acid}-EFVNWLLAGGPSSGAPPPSKKKKKK-NH2 | ||||||
| Formula | C225H346N56O65 | ||||||
| Molar Mass | 4875.49 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture and light, under nitrogen
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light, under nitrogen) |
DA-JC4
CAS: 2315504-40-4 F: C225H346N56O65 W: 4875.49
DA-JC4 is a dual GLP-1/GIP receptor agonist and can be used for the research of neurological disease and insulin signali
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.